Premium
Can serum HBV‐DNA be used as a primary end point to assess efficacy of new treatments for chronic hepatitis B?
Author(s) -
Alberti Alfredo
Publication year - 2003
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1053/jhep.2003.50280
Subject(s) - chronic hepatitis , citation , medicine , end point , library science , family medicine , virology , computer science , virus , real time computing